Graves’ Disease Caused by SARS-CoV-2 Infection

Graves’ Disease Caused by SARS-CoV-2 Infection

Graves’ disease is an autoimmune disorder that results in hyperthyroidism, caused by autoantibodies to the thyrotropin receptor (TRAbs) stimulating thyroid hormone synthesis, giving rise to a variety of systemic manifestations such as goitre, dermatopathy and orbitopathy. The authors present the c...

Full description

Bibliographic Details
Main Authors:	Bruno Sousa, Catarina Pestana Santos, Ana Gonçalves Ferreira, Tiago Judas
Format:	Article
Language:	English
Published:	SMC MEDIA SRL 2022-07-01
Series:	European Journal of Case Reports in Internal Medicine
Subjects:	graves’ disease sars-cov-2 hyperthyroidism
Online Access:	https://www.ejcrim.com/index.php/EJCRIM/article/view/3470

Similar Items

Recurrence of Graves’ Disease (a Th1-type Cytokine Disease) Following SARS-CoV-2 mRNA Vaccine Administration: A Simple Coincidence?
by: Guillaume Pierman, et al.
Published: (2021-09-01)

Graves’ Disease Following SARS-CoV-2 Vaccination: A Systematic Review
by: Armando Patrizio, et al.
Published: (2022-09-01)

SARS-CoV-2 mRNA vaccination and Graves' disease: a report of 12 cases and review of the literature
by: Chee, Ying Jie, et al.
Published: (2022)

Graves’ ophtalmopathy
by: Satvinder Bakshi
Published: (2022-02-01)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
by: Rosario Le Moli, et al.
Published: (2020-06-01)

Graves’ Thyrotoxicosis Following SARS-CoV-2 Infection
by: Asaf Harris, MD, et al.
Published: (2021-01-01)

Graves’ Ophthalmopathy Misdiagnosed as Relapsing Conjunctivitis
by: Irini P. Chatziralli, et al.
Published: (2010-09-01)

The change in the clinical presentation of Graves’ disease: a 30 years retrospective survey in an academic Brazilian tertiary center
by: Wanesa Pinto, et al.
Published: (2020-06-01)

Severe Cholestatic Syndrome Secondary to Graves’ Disease
by: Rodrigo Piltcher da Silva, et al.
Published: (2019-06-01)

New-onset and relapsed Graves’ disease following COVID-19 vaccination: a comprehensive review of reported cases
by: Kan Chen, et al.
Published: (2023-07-01)

Clinical manifestations of Graves’ disease among adults - a review of literature
by: Kamila Skoczylas, et al.
Published: (2023-06-01)

A 3-year-old girl with Graves' disease with literature review
by: Yo Han Ho, et al.
Published: (2014-09-01)

New-onset Graves’ disease following SARS-CoV-2 vaccination: a case report
by: Ringo Manta, et al.
Published: (2023-01-01)

Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients
by: Danilo Villagelin, et al.
Published: (2019-04-01)

The treatment of Graves' disease in children and adolescents
by: Hae Sang Lee, et al.
Published: (2014-09-01)

Unilateral pitting edema of the leg as a manifestation of Graves’ disease: a case report
by: Volke Vallo, et al.
Published: (2012-08-01)

Asymmetric Graves’ Orbitopathy
by: Grigorios Panagiotou, et al.
Published: (2020-12-01)

Graves hastalığına eşlik eden geçici yalancı trombositopeni
by: Esin BEYAN, et al.
Published: (2019-03-01)

Treatment of Graves’ disease in Brazil: results of a survey among endocrinologists
by: Danilo Villagelin, et al.
Published: (2023-07-01)

Two adolescent patients with coexistent Graves' disease and Moyamoya disease in Korea
by: Chong Kun Cheon, et al.
Published: (2014-06-01)

Graves‘ disease following vaccination against SARS-CoV-2: A systematic review of the reported cases
by: Konstantinos Katsikas Triantafyllidis, et al.
Published: (2022-09-01)

Neonatal Graves' Disease with Maternal Hypothyroidism
by: Gangaram Akangire, et al.
Published: (2017-07-01)

Graves' disease and idiopathic intracranial hypertension
by: Manish Gutch, et al.
Published: (2017-01-01)

Comparison of Fixed versus Calculated Activity of Radioiodine for the Treatment of Graves Disease in Adults
by: Abigail U. Canto, et al.
Published: (2016-03-01)

Subdural Hematoma in Grave’s Disease Induced Thrombocytopenia.
by: Sunil Kumar, et al.
Published: (2013-01-01)

Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves Disease
by: Hyemi Kwon, et al.
Published: (2016-06-01)

Case of Ovarian Cancer in a Woman with Undiagnosed Graves’ Disease: A Case Report and Review of the Literature
by: Timothy M. Markman, et al.
Published: (2017-05-01)

Preoperative preparation for Graves’ disease
by: Tianfeng Xu, et al.
Published: (2023-08-01)

Vitamin D Levels in Patients with Active and Remission Graves’ Disease
by: Natapon Rattanamusik, et al.
Published: (2023-07-01)

Bone Markers Status in Graves’ disease before and after Treatment
by: P Tofighi, et al.
Published: (2008-11-01)

Bone Markers Status in Graves’ disease before and after Treatment
by: P Tofighi, et al.
Published: (2008-11-01)

Massive cerebral venous sinus thrombosis secondary to Graves' disease
by: Hye-Min Son
Published: (2019-09-01)

Effect of Addition of Thyroxine in the Treatment of Graves’ Disease: A Systematic Review
by: Jun Li, et al.
Published: (2021-01-01)

Reproductive Function in Women with Graves’ Disease
Published: (2009-06-01)

Hyperthyroidism and Graves' disease: Is an ultrasound examination needed?
by: Lakshminarayanan Varadhan, et al.
Published: (2016-01-01)

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
by: Giulia Lanzolla, et al.
Published: (2021-01-01)

Characterization, treatment preferences, and outcomes of 390 Egyptian Graves’ disease patients: a retrospective study
by: Tamer Mohamed Elsherbiny
Published: (2023-08-01)

Pharmacological Survey of Graves\' Disease: A Mini Review
by: Akhtar Saifi, et al.
Published: (2021-04-01)

Livedo reticularis in Graves' disease: Just a coincidence?
by: Saurabh Gaba, et al.
Published: (2022-01-01)

Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves’ disease and its relationship to the degree of hyperthyroidism
by: Tianqi Liu, et al.
Published: (2022-08-01)